Comparative proteomic analysis of endothelial cells progenitor cells derived from cord blood- and peripheral blood for cell therapy

Biomaterials

Volumn 34, Issue 6, 2013, Pages 1669-1685

  Kim, Jumi ^a   Jeon, Young Joo ^c   Kim, Hye Eun ^b   Shin, Jeong Min ^a   Chung, Hyung Min ^a,b   Chae, Jung Il ^c  

^a CHA Bio and Diostech Co Ltd   (South Korea)

^b CHA University   (South Korea)

^c Chonbuk National University   (South Korea)

Author keywords

2 DE; BM; CB; CFL 1; Endothelial progenitor cell; EPC; GLO 1; HSP 27; NME 1; PARK 7; PB; Peripheral blood; PRDX 2; Proteomics; STMIN 1; Umbilical cord blood

Indexed keywords

2-DE; BM; CB; CFL 1; ENDOTHELIAL PROGENITOR CELLS; EPC; GLO 1; HSP 27; NME 1; PERIPHERAL BLOOD; PRDX 2; PROTEOMICS; STMIN 1; UMBILICAL CORD BLOOD;

BLOOD VESSELS; ENDOTHELIAL CELLS; HEART VALVE PROSTHESES; LEAD; MOLECULAR BIOLOGY; MOLECULES; STEM CELLS; TISSUE;

CYTOLOGY;

COFILIN 1; DJ 1 PROTEIN; GLYOXALASE; GLYOXALASE 1; HEAT SHOCK PROTEIN 27; NUCLEOSIDE DIPHOSPHATE KINASE A; PEROXIREDOXIN 2; STATHMIN; STATHMIN 1; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD VESSEL; CELL MIGRATION; CELL THERAPY; CORD BLOOD STEM CELL; ENDOTHELIUM CELL; HINDLIMB; HUMAN; HUMAN CELL; LIMB ISCHEMIA; MOUSE; NONHUMAN; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; UPREGULATION;

BLOTTING, WESTERN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FETAL BLOOD; HUMANS; IMMUNOHISTOCHEMISTRY; PROTEOMICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELLS; TANDEM MASS SPECTROMETRY; TISSUE THERAPY; UP-REGULATION;

EID: 84870817321     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.11.017     Document Type: Article

References (57)

1. Cuende N., Izeta A. Clinical translation of stem cell therapies: a bridgeable gap. Cell Stem Cell 2010, 6(6):508-512.
2. Taylor P.L., Barker R.A., Blume K.G., Cattaneo E., Colman A., Deng H., et al. Patients beware: commercialized stem cell treatments on the web. Cell Stem Cell 2010, 7(1):43-49.
3. Hodges H., Pollock K., Stroemer P., Patel S., Stevanato L., Reuter I., et al. Making stem cell lines suitable for transplantation. Cell Transplant 2007, 16(2):101-115.
4. Asahara T., Kawamoto A. Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol 2004, 287(3):C572-C579.
5. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275(5302):964-967.
6. Hur J., Yoon C.H., Kim H.S., Choi J.H., Kang H.J., Hwang K.K., et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004, 24(2):288-293.
7. Janic B., Guo A.M., Iskander A.S., Varma N.R., Scicli A.G., Arbab A.S. Human cord blood-derived AC133+ progenitor cells preserve endothelial progenitor characteristics after long term in vitro expansion. PLoS One 2010, 5(2):e9173.
8. Ingram D.A., Mead L.E., Tanaka H., Meade V., Fenoglio A., Mortell K., et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004, 104(9):2752-2760.
9. Murohara T. Cord blood-derived early outgrowth endothelial progenitor cells. Microvasc Res 2010, 79(3):174-177.
10. Melero-Martin J.M., Khan Z.A., Picard A., Wu X., Paruchuri S., Bischoff J. In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood 2007, 109(11):4761-4768.
11. Lin R.Z., Dreyzin A., Aamodt K., Dudley A.C., Melero-Martin J.M. Functional endothelial progenitor cells from cryopreserved umbilical cord blood. Cell Transplant 2011, 20(4):515-522.
12. Fuchs S., Dohle E., Kolbe M., Kirkpatrick C.J. Outgrowth endothelial cells: sources, characteristics and potential applications in tissue engineering and regenerative medicine. Adv Biochem Eng Biotechnol 2010, 123:201-217.
13. Mead L.E., Prater D., Yoder M.C., Ingram D.A. Isolation and characterization of endothelial progenitor cells from human blood. Curr Protoc Stem Cell Biol 2008, [Chapter 2:Unit 2C 1].
14. Huang G.P., Pan Z.J., Jia B.B., Zheng Q., Xie C.G., Gu J.H., et al. Ex vivo expansion and transplantation of hematopoietic stem/progenitor cells supported by mesenchymal stem cells from human umbilical cord blood. Cell Transplant 2007, 16(6):579-585.
15. Seo Y., Yang S.R., Jee M.K., Joo E.K., Roh K.H., Seo M.S., et al. Human umbilical cord blood-derived mesenchymal stem cells protect against neuronal cell death and ameliorate motor deficits in niemann pick type c1 mice. Cell Transplant 2011, 20(7):1033-1047.
16. Zhan M. Genomic studies to explore self-renewal and differentiation properties of embryonic stem cells. Front Biosci 2008, 13:276-283.
17. Nagano K., Taoka M., Yamauchi Y., Itagaki C., Shinkawa T., Nunomura K., et al. Large-scale identification of proteins expressed in mouse embryonic stem cells. Proteomics 2005, 5(5):1346-1361.
18. Stanton L.W., Bakre M.M. Genomic and proteomic characterization of embryonic stem cells. Curr Opin Chem Biol 2007, 11(4):399-404.
19. Lee M.J., Kim J., Lee K.I., Shin J.M., Chae J.I., Chung H.M. Enhancement of wound healing by secretory factors of endothelial precursor cells derived from human embryonic stem cells. Cytotherapy 2011, 13(2):165-178.
20. Shin J.M., Kim J., Kim H.E., Lee M.J., Lee K.I., Yoo E.G., et al. Enhancement of differentiation efficiency of hESCs into vascular lineage cells in hypoxia via a paracrine mechanism. Stem Cell Res 2011, 7(3):173-185.
21. Lee K.A., Shim J.H., Kho C.W., Park S.G., Park B.C., Kim J.W., et al. Protein profiling and identification of modulators regulated by the E7 oncogene in the C33A cell line by proteomics and genomics. Proteomics 2004, 4(3):839-848.
22. Shao B., Tang M., Li Z., Zhou R., Deng Y., Nie C., et al. Proteomics analysis of human umbilical vein endothelial cells treated with resveratrol. Amino Acids 2012, 43(4):1671-1678.
23. Cho S.W., Moon S.H., Lee S.H., Kang S.W., Kim J., Lim J.M., et al. Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation 2007, 116(21):2409-2419.
24. Lin S.Z. Advances in translational stem cell research and therapies. Cell Transplant 2011, 20(1):1-3.
25. Masuda H., Kalka C., Asahara T. Endothelial progenitor cells for regeneration. Hum Cell 2000, 13(4):153-160.
26. Harris D.T. Cord blood stem cells: a review of potential neurological applications. Stem Cell Rev 2008, 4(4):269-274.
27. Madeddu P., Emanueli C., Pelosi E., Salis M.B., Cerio A.M., Bonanno G., et al. Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs. FASEB J 2004, 18(14):1737-1739.
28. Murasawa S., Asahara T. Gene modified cell transplantation for vascular regeneration. Curr Gene Ther 2007, 7(1):1-6.
29. Kogler G., Critser P., Trapp T., Yoder M. Future of cord blood for non-oncology uses. Bone Marrow Transplant 2009, 44(10):683-697.
30. Haylock D.N., Nilsson S.K. Expansion of umbilical cord blood for clinical transplantation. Curr Stem Cell Res Ther 2007, 2(4):324-335.
31. Koike N., Fukumura D., Gralla O., Au P., Schechner J.S., Jain R.K. Tissue engineering: creation of long-lasting blood vessels. Nature 2004, 428(6979):138-139.
32. Au P., Daheron L.M., Duda D.G., Cohen K.S., Tyrrell J.A., Lanning R.M., et al. Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood 2008, 111(3):1302-1305.
33. Zenzmaier C., Kollroser M., Gesslbauer B., Jandrositz A., Preisegger K.H., Kungl A.J. Preliminary 2-D chromatographic investigation of the human stem cell proteome. Biochem Biophys Res Commun 2003, 310(2):483-490.
34. Tao W., Wang M., Voss E.D., Cocklin R.R., Smith J.A., Cooper S.H., et al. Comparative proteomic analysis of human CD34+ stem/progenitor cells and mature CD15+ myeloid cells. Stem Cells 2004, 22(6):1003-1014.
35. Zenzmaier C., Gesslbauer B., Grobuschek N., Jandrositz A., Preisegger K.H., Kungl A.J. Proteomic profiling of human stem cells derived from umbilical cord blood. Biochem Biophys Res Commun 2005, 328(4):968-972.
36. Liu F., Lu J., Fan H.H., Wang Z.Q., Cui S.J., Zhang G.A., et al. Insights into human CD34+ hematopoietic stem/progenitor cells through a systematically proteomic survey coupled with transcriptome. Proteomics 2006, 6(9):2673-2692.
37. D'Alessandro A., Liumbruno G., Grazzini G., Pupella S., Lombardini L., Zolla L. Umbilical cord blood stem cells: towards a proteomic approach. J Proteomics 2010, 73(3):468-482.
38. Balaji K.N., Schaschke N., Machleidt W., Catalfamo M., Henkart P.A. Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation. J Exp Med 2002, 196(4):493-503.
39. Jane D.T., DaSilva L., Koblinski J., Horwitz M., Sloane B.F., Dufresne M.J. Evidence for the involvement of cathepsin B in skeletal myoblast differentiation. J Cell Biochem 2002, 84(3):520-531.
40. Vanburen P., Palmer B.M. Cooperative activation of the cardiac myofilament: the pivotal role of tropomyosin. Circulation 2010, 121(3):351-353.
41. Mege R.M., Gavard J., Lambert M. Regulation of cell-cell junctions by the cytoskeleton. Curr Opin Cell Biol 2006, 18(5):541-548.
42. Pho M., Lee W., Watt D.R., Laschinger C., Simmons C.A., McCulloch C.A. Cofilin is a marker of myofibroblast differentiation in cells from porcine aortic cardiac valves. Am J Physiol Heart Circ Physiol 2008, 294(4):H1767-H1778.
43. Rajan S., Ahmed R.P., Jagatheesan G., Petrashevskaya N., Boivin G.P., Urboniene D., et al. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity. Circ Res 2007, 101(2):205-214.
44. Hu J.Y., Chu Z.G., Han J., Dang Y.M., Yan H., Zhang Q., et al. The p38/MAPK pathway regulates microtubule polymerization through phosphorylation of MAP4 and Op18 in hypoxic cells. Cell Mol Life Sci 2010, 67(2):321-333.
45. Arien-Zakay H., Lecht S., Bercu M.M., Tabakman R., Kohen R., Galski H., et al. Neuroprotection by cord blood neural progenitors involves antioxidants, neurotrophic and angiogenic factors. Exp Neurol 2009, 216(1):83-94.
46. Doll D., Sarikas A., Krajcik R., Zolk O. Proteomic expression analysis of cardiomyocytes subjected to proteasome inhibition. Biochem Biophys Res Commun 2007, 353(2):436-442.
47. Tosaki A., Edes I. The role of peroxiredoxins in ischemia-reperfusion-induced cardiac damage. Am J Physiol Heart Circ Physiol 2006, 291(6):H2586-H2587.
48. Chen F., Wollmer M.A., Hoerndli F., Munch G., Kuhla B., Rogaev E.I., et al. Role for glyoxalase I in Alzheimer's disease. Proc Natl Acad Sci U S A 2004, 101(20):7687-7692.
49. Chauhan S.C., Madhubala R. Glyoxalase I gene deletion mutants of leishmania donovani exhibit reduced methylglyoxal detoxification. PLoS One 2009, 4(8):e6805.
50. Shinohara M., Thornalley P.J., Giardino I., Beisswenger P., Thorpe S.R., Onorato J., et al. Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest 1998, 101(5):1142-1147.
51. Kumagai T., Nangaku M., Kojima I., Nagai R., Ingelfinger J.R., Miyata T., et al. Glyoxalase I overexpression ameliorates renal ischemia-reperfusion injury in rats. Am J Physiol Ren Physiol 2009, 296(4):F912-F921.
52. Hoffrogge R., Mikkat S., Scharf C., Beyer S., Christoph H., Pahnke J., et al. 2-DE proteome analysis of a proliferating and differentiating human neuronal stem cell line (ReNcell VM). Proteomics 2006, 6(6):1833-1847.
53. D'Alessandro Angelo, Grazzini Giuliano, Giardina Bruno, Zolla Lello In silico analyses of proteomic data suggest a role for heat shock proteins in umbilical cord blood hematopoietic stem cells. Stem Cell Rev 2010, 6(4):532-547.
54. Lescuyer P., Allard L., Zimmermann-Ivol C.G., Burgess J.A., Hughes-Frutiger S., Burkhard P.R., et al. Identification of post-mortem cerebrospinal fluid proteins as potential biomarkers of ischemia and neurodegeneration. Proteomics 2004, 4(8):2234-2241.
55. Saenger A.K., Christenson R.H. Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment. Clin Chem 2010, 56(1):21-33.
56. Ghen M.J., Roshan R., Roshan R.O., Blyweiss D.J., Corso N., Khalili B., et al. Potential clinical applications using stem cells derived from human umbilical cord blood. Reprod Biomed Online 2006, 13(4):562-572.
57. Trott D., McManus C.A., Martin J.L., Brennan B., Dunn M.J., Rose M.L. Effect of phosphorylated hsp27 on proliferation of human endothelial and smooth muscle cells. Proteomics 2009, 9(12):3383-3394.